SIRIO(SZ:300791) Huachuang Securities·2026-01-30 07:45Investment Rating - The report maintains a "Strong Buy" rating for the company, indicating an expectation to outperform the benchmark index by over 20% in the next six months [10]. Core Insights - The company has released its 2025 earnings forecast, projecting a net profit attributable to shareholders between 101 million to 151 million yuan, representing a year-on-year decline of 68.85% to 53.44% [2]. - The company has introduced a 2026 restricted stock incentive plan, granting 2.2025 million shares at a price of 12.21 yuan per share, covering 85 management and core technical personnel [2]. - The company aims for revenue targets of no less than 50.90 billion yuan, 53.83 billion yuan, and 58.32 billion yuan for the years 2026 to 2028, respectively [2]. - The company plans to dispose of its non-core personal care business, BFPC, and has fully provided for asset impairment of 195 million yuan, which is expected to enhance focus on its core business [8]. - The global nutrition and health food solutions market is projected to grow from 29.4 billion USD in 2024 to 42.4 billion USD by 2029, with a compound annual growth rate (CAGR) of 7.6% [11]. Financial Summary - Total revenue is expected to reach 4.533 billion yuan in 2025, with a year-on-year growth rate of 7.6% [10]. - The net profit attributable to shareholders is projected to be 121 million yuan in 2025, reflecting a significant decline of 62.7% compared to the previous year [10]. - The company’s earnings per share (EPS) is forecasted to be 0.39 yuan in 2025, with a price-to-earnings (P/E) ratio of 60 [10].